| MLEC | Moolec Science SA | 0.01 | -99.89% |
| LSB | LakeShore Biopharma Co Ltd | 0.02 | -99.72% |
| ENVB | Enveric Biosciences Inc | 0.08 | -99.03% |
| KPRX | Kiora Pharmaceuticals Inc | 0.14 | -98.23% |
| JAGX | Jaguar Health Inc | 0.30 | -96.26% |
| LITS | Lite Strategy Inc | 0.31 | -96.15% |
| HRTX | Heron Therapeutics Inc | 0.51 | -93.76% |
| AFMD | Affimed N.V. | 0.53 | -93.51% |
| FTRE | Fortrea Holdings Inc | 0.57 | -92.98% |
| BDRX | Biodexa Pharmaceuticals Plc | 0.58 | -92.92% |
| ENSC | Ensysce Biosciences Inc | 0.61 | -92.49% |
| CLSD | Clearside Biomedical, Inc. Common Stock | 0.64 | -92.08% |
| ONCT | Oncternal Therapeutics Inc | 0.72 | -91.14% |
| SRPT | Sarepta Therapeutics Inc | 0.73 | -90.99% |
| CELU | Celularity Inc - Class A | 0.85 | -89.58% |
| GOSS | Gossamer Bio Inc | 0.98 | -88.01% |
| XLO | Xilio Therapeutics Inc | 0.98 | -87.96% |
| SCNI | Scinai Immunotherapeutics Ltd | 1.00 | -87.75% |
| AGEN | Agenus Inc | 1.05 | -87.15% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | 1.12 | -86.26% |
| FBIOP | Fortress Biotech Inc | 1.25 | -84.67% |
| IMRN | Immuron Ltd | 1.30 | -84.03% |
| KPTI | Karyopharm Therapeutics Inc | 1.30 | -83.99% |
| BOLT | Bolt Biotherapeutics Inc | 1.31 | -83.90% |
| HCWB | HCW Biologics Inc | 1.31 | -83.84% |
| CSBR | Champions Oncology Inc | 1.39 | -82.95% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | 1.39 | -82.86% |
| MDXG | Mimedx Group Inc | 1.42 | -82.57% |
| RVNC | Revance Therapeutics Inc | 1.48 | -81.81% |
| FBIO | Fortress Biotech Inc | 1.51 | -81.39% |
| ONCO | Onconetix Inc | 1.54 | -81.13% |
| AVIR | Atea Pharmaceuticals Inc | 1.55 | -80.92% |
| PBYI | Puma Biotechnology Inc | 1.62 | -80.10% |
| MGNX | Macrogenics Inc | 1.62 | -80.06% |
| VNDA | Vanda Pharmaceuticals Inc | 1.69 | -79.24% |
| CRMD | CorMedix Inc | 1.70 | -79.16% |
| NEUP | Neuphoria Therapeutics Inc | 1.70 | -79.10% |
| GLPG | Galapagos NV | 1.74 | -78.62% |
| ADCT | Adc Therapeutics SA | 1.77 | -78.29% |
| SVA | Sinovac Biotech Ltd | 1.83 | -77.50% |
| NERV | Minerva Neurosciences Inc | 1.87 | -77.05% |
| RIGL | Rigel Pharmaceuticals | 1.90 | -76.71% |
| PTN | Palatin Technologies Inc | 1.96 | -75.91% |
| THTX | Theratechnologies Inc | 1.98 | -75.63% |
| MGX | Metagenomi Inc | 2.07 | -74.52% |
| PLX | Protalix BioTherapeutics Inc | 2.09 | -74.33% |
| BDTX | Black Diamond Therapeutics Inc | 2.11 | -74.05% |
| NAGE | Niagen Bioscience Inc | 2.12 | -73.97% |
| XBIO | Xenetic Biosciences Inc | 2.21 | -72.80% |
| RADX | Radiopharm Theranostics Ltd | 2.22 | -72.75% |
| HRMY | Harmony Biosciences Holdings Inc | 2.28 | -71.94% |
| SPRC | SciSparc Ltd | 2.33 | -71.35% |
| PHAR | Pharming Group N.V. | 2.36 | -71.04% |
| NVAX | Novavax Inc | 2.39 | -70.62% |
| SPRO | Spero Therapeutics Inc | 2.42 | -70.23% |
| GNFT | GENFIT S.A. American Depositary Shares | 2.44 | -70.07% |
| CRIS | Curis Inc | 2.47 | -69.69% |
| SAVA | Cassava Sciences Inc. | 2.54 | -68.83% |
| CGEN | Compugen Ltd | 2.63 | -67.69% |
| FULC | Fulcrum Therapeutics Inc | 2.66 | -67.36% |
| VRCA | Verrica Pharmaceuticals Inc | 2.66 | -67.34% |
| HYFT | MindWalk Holdings Corp | 2.68 | -67.10% |
| CTXR | Citius Pharmaceuticals Inc | 2.69 | -66.89% |
| APVO | Aptevo Therapeutics Inc | 2.70 | -66.78% |
| SXTP | 60 Degrees Pharmaceuticals Inc | 2.79 | -65.71% |
| AAPG | Ascentage Pharma Group International | 2.86 | -64.85% |
| CDXS | Codexis Inc | 2.88 | -64.68% |
| REVB | Revelation Biosciences Inc | 2.88 | -64.59% |
| ICCC | Immucell Corp | 2.95 | -63.72% |
| SABS | SAB Biotherapeutics Inc | 2.96 | -63.64% |
| MNKD | Mannkind Corp | 3.06 | -62.44% |
| VALN | Valneva SE | 3.11 | -61.74% |
| BCAB | BioAtla Inc | 3.20 | -60.65% |
| ARDX | Ardelyx Inc | 3.23 | -60.25% |
| JAZZ | Jazz Pharmaceuticals plc | 3.24 | -60.14% |
| BGMS | Bio Green Med Solution Inc | 3.27 | -59.76% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | 3.32 | -59.18% |
| EVGN | Evogene Ltd | 3.32 | -59.16% |
| RARE | Ultragenyx Pharmaceutical Inc | 3.35 | -58.84% |
| ACAD | Acadia Pharmaceuticals Inc | 3.42 | -58.04% |
| APLM | Apollomics Inc - Class A | 3.42 | -57.92% |
| IMCR | Immunocore Holdings plc | 3.44 | -57.76% |
| PTHS | Channel Therapeutics Corporation | 3.44 | -57.73% |
| BMRN | Biomarin Pharmaceutical Inc | 3.45 | -57.59% |
| CUE | Cue Biopharma Inc | 3.58 | -56.08% |
| ARCT | Arcturus Therapeutics Holdings Inc | 3.62 | -55.50% |
| SLDB | Solid Biosciences Inc | 3.65 | -55.22% |
| GERN | Geron Corp | 3.66 | -54.98% |
| DTIL | Precision Biosciences Inc | 3.69 | -54.64% |
| IPSC | Century Therapeutics Inc | 3.72 | -54.33% |
| RGNX | Regenxbio Inc | 3.77 | -53.64% |
| ADMA | Adma Biologics Inc | 3.78 | -53.53% |
| BRNS | Barinthus Biotherapeutics Plc. | 3.80 | -53.32% |
| ATRA | Atara Biotherapeutics Inc | 3.80 | -53.26% |
| PHAT | Phathom Pharmaceuticals Inc | 3.82 | -53.04% |
| INCY | Incyte Corp | 3.85 | -52.73% |
| GMAB | Genmab | 3.85 | -52.65% |
| INVA | Innoviva Inc | 3.96 | -51.41% |
| TLX | Telix Pharmaceuticals Ltd | 3.97 | -51.27% |
| QTTB | Q32 Bio Inc | 4.06 | -50.11% |
| EVAX | Evaxion Biotech A/S | 4.20 | -48.41% |
| CLLS | Cellectis | 4.29 | -47.34% |
| ZLAB | Zai Lab Ltd | 4.31 | -47.01% |
| REGN | Regeneron Pharmaceuticals Inc | 4.33 | -46.80% |
| STRO | Sutro Biopharma Inc | 4.34 | -46.68% |
| ABUS | Arbutus Biopharma Corp | 4.34 | -46.63% |
| BCYC | Bicycle Therapeutics Plc | 4.43 | -45.56% |
| YMAB | Y-Mabs Therapeutics Inc | 4.57 | -43.85% |
| CHRS | Coherus Biosciences Inc | 4.67 | -42.60% |
| TRAW | Traws Pharma Inc | 4.70 | -42.30% |
| IVVD | Invivyd Inc | 4.75 | -41.63% |
| ONC | BeiGene Ltd | 4.77 | -41.44% |
| ENTA | Enanta Pharmaceuticals Inc | 4.77 | -41.41% |
| TARS | Tarsus Pharmaceuticals Inc | 4.93 | -39.48% |
| GYRE | Gyre Therapeutics Inc | 4.93 | -39.40% |
| ARVN | Arvinas Inc | 5.04 | -38.08% |
| ACHV | Achieve Life Sciences Inc | 5.09 | -37.46% |
| FDMT | 4D Molecular Therapeutics Inc | 5.17 | -36.48% |
| ELAB | PMGC Holdings Inc | 5.26 | -35.36% |
| CAI | Caris Life Sciences Inc - Class A | 5.35 | -34.27% |
| RNA | Atrium Therapeutics Inc | 5.51 | -32.30% |
| OSRH | Bellevue Life Sciences Acquisition Corp | 5.58 | -31.44% |
| HALO | Halozyme Therapeutics Inc | 5.62 | -30.95% |
| EXEL | Exelixis Inc | 5.66 | -30.46% |
| LEGN | Legend Biotech Corp | 5.68 | -30.21% |
| VYGR | Voyager Therapeutics Inc | 5.74 | -29.48% |
| KROS | Keros Therapeutics Inc | 5.92 | -27.26% |
| FENC | Fennec Pharmaceuticals Inc | 5.93 | -27.14% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | 6.02 | -26.09% |
| IOVA | Iovance Biotherapeutics Inc | 6.03 | -25.91% |
| SCPH | scPharmaceuticals Inc | 6.10 | -25.11% |
| SEER | Seer Inc - Class A | 6.13 | -24.68% |
| ASMB | Assembly Biosciences Inc | 6.37 | -21.74% |
| CPRX | Catalyst Pharmaceuticals Inc | 6.43 | -21.00% |
| DYAI | Dyadic International Inc DE | 6.46 | -20.63% |
| VCEL | Vericel Corp | 6.47 | -20.51% |
| ZVRA | Zevra Therapeutics Inc | 6.53 | -19.77% |
| IMMP | Immutep Ltd | 6.62 | -18.66% |
| ANAB | AnaptysBio Inc | 6.63 | -18.54% |
| CYCN | Cyclerion Therapeutics Inc | 6.71 | -17.56% |
| MRKR | Marker Therapeutics Inc | 6.72 | -17.44% |
| VSTM | Verastem Inc | 6.77 | -16.82% |
| ALGS | Aligos Therapeutics Inc | 6.79 | -16.58% |
| AUPH | Aurinia Pharmaceuticals Inc | 6.87 | -15.59% |
| ARQT | Arcutis Biotherapeutics Inc | 6.99 | -14.12% |
| TECH | Bio-Techne Corp | 7.04 | -13.50% |
| ZNTL | Zentalis Pharmaceuticals Inc | 7.13 | -12.40% |
| TCRX | Tscan Therapeutics Inc | 7.14 | -12.32% |
| PSTV | Plus Therapeutics Inc | 7.16 | -12.03% |
| SNDX | Syndax Pharmaceuticals Inc | 7.21 | -11.42% |
| ICU | SeaStar Medical Holding Corp | 7.32 | -10.06% |
| OBIO | Orchestra BioMed Holdings Inc | 7.36 | -9.57% |
| PTCT | PTC Therapeutics Inc | 7.39 | -9.20% |
| PYXS | Pyxis Oncology Inc | 7.57 | -6.99% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | 7.58 | -6.92% |
| PRTA | Prothena Corporation plc | 7.65 | -6.01% |
| NTBL | Notable Labs Inc Ord | 7.65 | -6.01% |
| TBPH | Theravance Biopharma Inc | 7.74 | -4.90% |
| BNTX | BioNTech SE | 7.77 | -4.53% |
| FHTX | Foghorn Therapeutics Inc | 8.01 | -1.59% |
| TVTX | Travere Therapeutics Inc | 8.11 | -0.36% |
| ARTV | Artiva Biotherapeutics Inc | 8.11 | -0.36% |
| LPCN | Lipocine Inc | 8.44 | +3.70% |
| MRNA | Moderna Inc | 8.51 | +4.56% |
| XNCR | Xencor Inc | 9.05 | +11.19% |
| GOVX | Geovax Labs Inc | 9.09 | +11.68% |
| ALEC | Alector Inc | 9.16 | +12.54% |
| VRTX | Vertex Pharmaceuticals Inc | 9.26 | +13.77% |
| ALNY | Alnylam Pharmaceuticals Inc | 9.27 | +13.89% |
| SPRY | ARS Pharmaceuticals Inc | 9.29 | +14.14% |
| TGTX | TG Therapeutics Inc | 9.48 | +16.47% |
| NXTC | Nextcure Inc | 9.52 | +16.97% |
| MDGL | Madrigal Pharmaceuticals Inc | 9.68 | +18.93% |
| ACET | Adicet Bio Inc | 9.72 | +19.42% |
| SNGX | Soligenix Inc | 9.78 | +20.16% |
| URGN | UroGen Pharma Ltd | 9.78 | +20.16% |
| LENZ | LENZ Therapeutics Inc | 9.83 | +20.77% |
| MIRM | Mirum Pharmaceuticals Inc | 10.06 | +23.60% |
| HOWL | Werewolf Therapeutics Inc | 10.21 | +25.44% |
| BLRX | Bioline Rx Ltd | 10.30 | +26.55% |
| IKT | Inhibikase Therapeutics Inc | 10.39 | +27.66% |
| TNXP | Tonix Pharmaceuticals Holding Corp | 10.41 | +27.90% |
| MGTX | MeiraGTx Holdings plc | 10.61 | +30.36% |
| CORT | Corcept Therapeutics Inc | 10.82 | +32.94% |
| XOMA | XOMA Corp | 10.84 | +33.18% |
| NUVB | Nuvation Bio Inc - Class A | 11.15 | +36.99% |
| CTNM | Contineum Therapeutics Inc - Class A | 11.15 | +36.99% |
| KURA | Kura Oncology Inc | 11.19 | +37.48% |
| ATHE | Alterity Therapeutics Ltd | 11.33 | +39.20% |
| BCDA | BioCardia Inc | 11.35 | +39.45% |
| PRQR | ProQR Therapeutics N.V | 11.36 | +39.57% |
| IDYA | Ideaya Biosciences Inc | 11.59 | +42.40% |
| CCCC | C4 Therapeutics Inc | 11.61 | +42.64% |
| ARGX | Argen X SE | 11.62 | +42.77% |
| IONS | Ionis Pharmaceuticals Inc | 11.72 | +44.00% |
| PALI | Palisade Bio Inc | 11.78 | +44.73% |
| RCUS | Arcus Biosciences Inc | 11.79 | +44.86% |
| OABI | OmniAb Inc | 11.92 | +46.45% |
| LXRX | Lexicon Pharmaceuticals Inc | 11.99 | +47.31% |
| ACOG | Alpha Cognition Inc | 12.05 | +48.05% |
| XBIT | XBiotech Inc | 12.23 | +50.26% |
| KALV | KalVista Pharmaceuticals Inc | 12.55 | +54.19% |
| MDWD | MediWound Ltd | 12.69 | +55.91% |
| CRVO | CervoMed Inc | 12.81 | +57.39% |
| SLGL | Sol-Gel Technologies Ltd | 13.01 | +59.85% |
| COYA | Coya Therapeutics Inc | 13.03 | +60.09% |
| RPRX | Royalty Pharma plc - Class A | 13.13 | +61.32% |
| SRRK | Scholar Rock Holding Corp | 13.14 | +61.44% |
| CLGN | CollPlant Biotechnologies Ltd New | 13.46 | +65.37% |
| ANL | Adlai Nortye Ltd | 13.52 | +66.16% |
| XCUR | Exicure Inc | 13.61 | +67.22% |
| EDIT | Editas Medicine Inc | 13.68 | +68.08% |
| GDTC | CytoMed Therapeutics Ltd | 14.64 | +79.87% |
| CVAC | CureVac N.V. | 14.83 | +82.21% |
| APLT | Applied Therapeutics Inc | 14.86 | +82.58% |
| CRBU | Caribou Biosciences Inc | 15.23 | +87.12% |
| ASND | Ascendis Pharma A/S | 15.38 | +88.96% |
| CANF | Can-Fite Biopharma Ltd | 15.39 | +89.09% |
| WVE | Wave Life Sciences Ltd | 15.48 | +90.19% |
| ARWR | Arrowhead Pharmaceuticals Inc | 16.61 | +104.08% |
| LGND | Ligand Pharmaceuticals Inc - Class B | 17.76 | +118.21% |
| IMNN | Imunon Inc | 17.94 | +120.42% |
| IPHA | Innate Pharma | 18.25 | +124.23% |
| AXSM | Axsome Therapeutics Inc | 18.26 | +124.35% |
| CTMX | CytomX Therapeutics Inc | 18.28 | +124.59% |
| BEAM | Beam Therapeutics Inc | 18.35 | +125.45% |
| PRLD | Prelude Therapeutics Inc | 18.82 | +131.23% |
| SEPN | Septerna Inc | 19.01 | +133.56% |
| ABCL | AbCellera Biologics Inc | 19.62 | +141.06% |
| NRXS | Neuraxis Inc | 19.67 | +141.67% |
| LGVN | Longeveron Inc - Class A | 20.01 | +145.85% |
| EQ | Equillium Inc | 20.22 | +148.43% |
| NTRB | Nutriband Inc | 20.35 | +150.03% |
| LIXT | Lixte Biotechnology Holdings Inc | 20.35 | +150.03% |
| ZYME | Zymeworks BC Inc | 20.65 | +153.71% |
| LCTX | Lineage Cell Therapeutics Inc | 20.75 | +154.94% |
| ABEO | Abeona Therapeutics Inc | 21.68 | +166.37% |
| NRIX | Nurix Therapeutics Inc | 22.04 | +170.79% |
| KRYS | Krystal Biotech Inc | 22.46 | +175.95% |
| PLUR | Pluri Inc | 22.60 | +177.67% |
| BBIO | BridgeBio Pharma Inc | 22.76 | +179.64% |
| APM | Aptorum Group Ltd - Class A | 23.35 | +186.89% |
| UNCY | Unicycive Therapeutics Inc | 23.75 | +191.80% |
| KALA | Kala Bio Inc | 23.75 | +191.80% |
| VIVS | VivoSim Labs Inc | 24.05 | +195.49% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | 24.06 | +195.61% |
| VRDN | Viridian Therapeutics Inc | 24.56 | +201.75% |
| AGIO | Agios Pharmaceuticals Inc | 25.34 | +211.34% |
| NBP | NovaBridge Biosciences. | 25.39 | +211.95% |
| DARE | Dare Bioscience Inc | 25.50 | +213.30% |
| RNXT | RenovoRx Inc | 25.79 | +216.87% |
| IGC | IGC Pharma Inc | 25.79 | +216.87% |
| CGEM | Cullinan Oncology Inc | 25.86 | +217.73% |
| INSM | Insmed Inc | 26.19 | +221.78% |
| CBUS | Cibus Global Ltd. Class A | 26.70 | +228.05% |
| BRTX | BioRestorative Therapies Inc | 26.77 | +228.91% |
| IRD | Ocuphire Pharma Inc | 26.80 | +229.27% |
| SLS | SELLAS Life Sciences Group Inc | 26.90 | +230.50% |
| NTLA | Intellia Therapeutics Inc | 27.23 | +234.56% |
| ABVC | ABVC BioPharma Inc | 27.42 | +236.89% |
| VTGN | VistaGen Therapeutics Inc | 27.63 | +239.47% |
| RYTM | Rhythm Pharmaceuticals Inc | 27.90 | +242.79% |
| WHWK | Whitehawk Therapeutics Inc | 30.04 | +269.08% |
| ADAG | Adagene Inc | 30.75 | +277.81% |
| IMTX | Immatics N.V | 32.50 | +299.31% |
| GLUE | Monte Rosa Therapeutics Inc | 32.74 | +302.26% |
| RANI | Rani Therapeutics Holdings Inc Class A | 33.95 | +317.12% |
| NKTR | Nektar Therapeutics | 34.15 | +319.58% |
| MESO | Mesoblast Ltd | 34.34 | +321.91% |
| SRZN | Surrozen Inc | 34.52 | +324.13% |
| MTNB | Matinas Biopharma Holdings Inc | 34.81 | +327.69% |
| OCUL | Ocular Therapeutix Inc | 35.64 | +337.89% |
| FATE | Fate Therapeutics Inc | 36.36 | +346.73% |
| HYPD | Eyenovia Inc | 36.62 | +349.93% |
| TOVX | Theriva Biologics Inc | 37.25 | +357.67% |
| XFOR | X4 Pharmaceuticals Inc | 39.03 | +379.54% |
| KRRO | Korro Bio Inc | 39.75 | +388.38% |
| CBIO | N/A | 40.77 | +400.91% |
| KTTA | Pasithea Therapeutics Corp | 42.15 | +417.87% |
| TRDA | Entrada Therapeutics Inc | 42.62 | +423.64% |
| PGEN | Precigen Inc | 43.89 | +439.25% |
| LEXX | Lexaria Bioscience Corp | 44.19 | +442.93% |
| BYSI | BeyondSpring Inc | 45.99 | +465.05% |
| ADXN | Addex Therapeutics Ltd | 47.60 | +484.83% |
| PHIO | Phio Pharmaceuticals Corp | 48.01 | +489.87% |
| VYNE | VYNE Therapeutics Inc | 48.39 | +494.54% |
| SPRB | Spruce Biosciences Inc | 49.19 | +504.37% |
| CLDI | Calidi Biotherapeutics Inc | 50.83 | +524.52% |
| IBRX | ImmunityBio Inc | 51.86 | +537.17% |
| PPBT | Purple Biotech Ltd | 51.90 | +537.64% |
| NBTX | Nanobiotix | 52.28 | +542.33% |
| SGMT | Sagimet Biosciences Inc - Class A | 52.50 | +545.03% |
| ARMP | Armata Pharmaceuticals Inc | 53.35 | +555.48% |
| KZIA | Kazia Therapeutics Ltd | 53.44 | +556.59% |
| STOK | Stoke Therapeutics Inc | 55.29 | +579.31% |
| MCRB | Seres Therapeutics Inc | 55.92 | +587.05% |
| CAMP | CAMP4 Therapeutics Corp | 57.28 | +603.76% |
| JANX | Janux Therapeutics Inc | 58.53 | +619.12% |
| ONCY | Oncolytics Biotech Inc | 58.60 | +619.98% |
| ACIU | AC Immune SA | 58.97 | +624.53% |
| PRTC | PureTech Health plc American Depositary Shares | 59.84 | +635.22% |
| GLMD | Galmed Pharmaceuticals Ltd | 61.38 | +654.14% |
| OVID | Ovid Therapeutics Inc | 62.50 | +667.90% |
| COCP | Cocrystal Pharma Inc | 62.50 | +667.90% |
| MAZE | Maze Therapeutics Inc | 65.47 | +704.39% |
| EPIX | Essa Pharma Inc | 65.79 | +708.29% |
| DMAC | DiaMedica Therapeutics Inc | 66.68 | +719.25% |
| NRXP | NRX Pharmaceuticals Inc | 70.46 | +765.70% |
| ACRS | Aclaris Therapeutics Inc | 72.11 | +785.97% |
| OMER | Omeros Corporation | 72.94 | +796.17% |
| TNGX | Tango Therapeutics Inc | 73.25 | +799.98% |
| IVA | Inventiva | 73.66 | +805.01% |
| EVMN | Evommune Inc | 73.80 | +806.73% |
| ALLR | Allarity Therapeutics Inc | 74.08 | +810.17% |
| APRE | Aprea Therapeutics Inc | 74.64 | +817.05% |
| IMA | Ikena Oncology Inc | 83.32 | +923.70% |
| RAPP | Rapport Therapeutics Inc | 84.20 | +934.51% |
| ORMP | Oramed Pharmaceuticals Inc | 86.55 | +963.38% |
| CYTK | Cytokinetics Inc | 87.83 | +979.11% |
| OGEN | Oragenics Inc | 89.28 | +996.93% |
| OCGN | Ocugen Inc | 90.22 | +1008.48% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | 91.86 | +1028.63% |
| QURE | uniQure N.V. | 92.23 | +1033.17% |
| CVM | Cel-Sci Corp | 92.88 | +1041.16% |
| ADVM | Adverum Biotechnologies Inc | 94.37 | +1059.46% |
| PTGX | Protagonist Therapeutics Inc | 95.50 | +1073.35% |
| SILO | SILO Pharma Inc | 96.26 | +1082.69% |
| AEON | AEON Biopharma Inc - Class A | 97.16 | +1093.74% |
| MREO | Mereo Biopharma Group Plc | 97.27 | +1095.09% |
| MIST | Milestone Pharmaceuticals Inc | 98.25 | +1107.13% |
| HIND | ReShape Lifesciences Inc | 99.95 | +1128.02% |
| UPB | Upstream Bio Inc | 102.88 | +1164.02% |
| RLYB | Rallybio Corp | 107.21 | +1217.22% |
| MNOV | Medicinova Inc | 107.25 | +1217.71% |
| HUMA | Humacyte Inc | 115.08 | +1313.91% |
| SKYE | Skye Bioscience Inc | 117.90 | +1348.56% |
| ZBIO | Zenas Biopharma Inc | 119.50 | +1368.22% |
| AIM | AIM ImmunoTech Inc. | 120.98 | +1386.40% |
| PRME | Prime Medicine Inc | 121.34 | +1390.83% |
| CAPR | Capricor Therapeutics Inc | 124.43 | +1428.79% |
| KYMR | Kymera Therapeutics Inc | 125.01 | +1435.92% |
| RNAC | Cartesian Therapeutics Inc | 127.79 | +1470.07% |
| EYPT | EyePoint Pharmaceuticals Inc | 135.77 | +1568.12% |
| OPT | Opthea Ltd | 151.40 | +1760.11% |
| NAMS | NewAmsterdam Pharma Company NV | 151.95 | +1766.91% |
| MOLN | Molecular Partners AG | 156.56 | +1823.55% |
| DBVT | DBV Technologies | 165.40 | +1932.16% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 169.88 | +1987.21% |
| GRDX | Entero Therapeutics Inc | 182.31 | +2139.93% |
| CRDF | Cardiff Oncology Inc | 192.74 | +2268.07% |
| LSTA | Lisata Therapeutics Inc | 193.38 | +2275.94% |
| GRCE | Acasti Pharma Inc | 197.75 | +2329.63% |
| CRNX | Crinetics Pharmaceuticals Inc | 200.27 | +2360.59% |
| SER | AgeX Therapeutics Inc | 200.74 | +2366.36% |
| GTBP | GT Biopharma Inc | 204.96 | +2418.21% |
| TSHA | Taysha Gene Therapies Inc | 207.70 | +2451.88% |
| ASBP | Aspire Biopharma Holdings Inc | 210.28 | +2483.58% |
| AZTR | Azitra Inc | 239.97 | +2848.36% |
| ATYR | Atyr Pharma Inc | 241.72 | +2869.86% |
| GANX | Gain Therapeutics Inc | 255.50 | +3039.17% |
| CMPX | Compass Therapeutics Inc | 269.28 | +3208.47% |
| RLAY | Relay Therapeutics Inc | 275.39 | +3283.54% |
| CYBN | Cybin Inc | 278.25 | +3318.68% |
| IBIO | iBio Inc | 311.32 | +3724.99% |
| STTK | Shattuck Labs Inc | 314.77 | +3767.38% |
| SLN | Silence Therapeutics Plc | 337.79 | +4050.21% |
| CDIO | Cardio Diagnostics Holdings Inc | 344.81 | +4136.46% |
| CLRB | Cellectar Biosciences Inc | 348.47 | +4181.43% |
| VRNA | Verona Pharma Plc | 350.73 | +4209.20% |
| ATNM | Actinium Pharmaceuticals Inc | 352.10 | +4226.03% |
| AUTL | Autolus Therapeutics plc | 365.22 | +4387.22% |
| ALMS | Alumis Inc | 366.45 | +4402.34% |
| ANIX | Anixa Biosciences Inc | 377.78 | +4541.54% |
| ATAI | ATAI Life Sciences N.V. | 395.29 | +4756.68% |
| OTLK | Outlook Therapeutics Inc | 396.96 | +4777.19% |
| CNTA | Centessa Pharmaceuticals plc | 409.21 | +4927.70% |
| TENX | Tenax Therapeutics Inc | 414.72 | +4995.40% |
| YDES | YD Bio Ltd | 430.93 | +5194.56% |
| CADL | Candel Therapeutics Inc | 436.42 | +5262.01% |
| NGNE | Neoleukin Therapeutics Inc | 438.73 | +5290.40% |
| JUNS | Jupiter Neurosciences Inc | 448.27 | +5407.61% |
| LXEO | Lexeo Therapeutics Inc | 478.26 | +5776.07% |
| LNAI | Lunai Bioworks Inc | 489.28 | +5911.47% |
| IMNM | Immunome Inc | 512.24 | +6193.57% |
| ABSI | Absci Corp | 532.00 | +6436.34% |
| ABOS | Acumen Pharmaceuticals Inc | 538.78 | +6519.65% |
| TVRD | Cara Therapeutics Inc | 559.61 | +6775.57% |
| IMRX | Immuneering Corp Class A | 563.62 | +6824.84% |
| CNTB | Connect Biopharma Holdings Ltd | 581.00 | +7038.38% |
| OCS | Oculis Holding AG | 590.44 | +7154.36% |
| SYRE | Spyre Therapeutics Inc | 650.22 | +7888.84% |
| TNYA | Tenaya Therapeutics Inc | 662.57 | +8040.57% |
| XENE | Xenon Pharmaceuticals Inc | 727.44 | +8837.59% |
| GRCL | Gracell Biotechnologies Inc | 732.21 | +8896.20% |
| INMB | INmune Bio Inc | 760.34 | +9241.81% |
| SNTI | Senti Biosciences Inc | 786.90 | +9568.14% |
| VRAX | Virax Biolabs Group Ltd - Class A | 793.06 | +9643.82% |
| COGT | Cogent Biosciences Inc | 861.15 | +10480.40% |
| PROK | ProKidney Corp - Class A | 876.39 | +10667.64% |
| PRAX | Praxis Precision Medicines Inc | 953.14 | +11610.62% |
| CGON | Cg Oncology Inc | 955.25 | +11636.55% |
| INBX | Inhibrx Biosciences Inc | 1009.72 | +12305.78% |
| CRSP | CRISPR Therapeutics AG | 1241.19 | +15149.71% |
| ERNA | Ernexa Therapeutics Inc | 1275.37 | +15569.66% |
| PCSA | Processa Pharmaceuticals Inc | 1320.06 | +16118.73% |
| TTNP | Titan Pharmaceuticals Inc (de) | 1459.05 | +17826.41% |
| ENTX | Entera Bio Ltd | 1547.08 | +18907.98% |
| IBO | Impact BioMedical Inc | 1573.08 | +19227.43% |
| ABVX | Abivax | 1589.40 | +19427.94% |
| INO | Inovio Pharmaceuticals Inc | 1712.37 | +20938.80% |
| TCRT | Alaunos Therapeutics Inc | 1774.63 | +21703.74% |
| ATOS | Atossa Therapeutics Inc | 1872.06 | +22900.80% |
| MBIO | Mustang Bio Inc | 2205.73 | +27000.39% |
| PULM | Pulmatrix Inc | 2459.21 | +30114.74% |
| ROIV | Roivant Sciences Ltd | 2538.35 | +31087.08% |
| CELZ | Creative Medical Technology Holdings Inc | 2618.47 | +32071.47% |
| CLDX | Celldex Therapeutics Inc | 2685.97 | +32900.80% |
| BNTC | Benitec Biopharma Inc | 2770.13 | +33934.82% |
| PLRX | Pliant Therapeutics Inc | 3071.82 | +37641.49% |
| DNTH | Dianthus Therapeutics Inc | 3126.94 | +38318.71% |
| NTHI | NeOnc Technologies Holdings Inc | 3477.63 | +42627.42% |
| KYTX | Kyverna Therapeutics Inc | 3513.34 | +43066.16% |
| CMRX | Chimerix Inc | 3613.35 | +44294.92% |
| DNLI | Denali Therapeutics Inc | 3643.65 | +44667.20% |
| SMMT | Summit Therapeutics Inc | 3891.31 | +47710.04% |
| PMN | ProMIS Neurosciences Inc | 4016.22 | +49244.73% |
| ALXO | Alx Oncology Holdings Inc | 5085.96 | +62387.94% |
| IFRX | InflaRx N.V. | 6161.81 | +75606.22% |
| GUTS | Fractyl Health Inc | 7575.74 | +92978.27% |
| ALLO | Allogene Therapeutics Inc | 7784.36 | +95541.45% |
| LPTX | Leap Therapeutics Inc | 8475.88 | +104037.68% |
| RLMD | Relmada Therapeutics Inc | 9001.90 | +110500.59% |
| RVMD | Revolution Medicines Inc | 9035.10 | +110908.50% |
| AVTX | Avalo Therapeutics Inc | 9875.25 | +121230.88% |
| LYEL | Lyell Immunopharma Inc | 10048.71 | +123362.08% |
| ALT | Altimmune Inc | 10694.01 | +131290.46% |
| PMCB | PharmaCyte Biotech Inc | 12904.41 | +158448.24% |
| GNLX | Genelux Corp | 16030.45 | +196855.89% |
| VTVT | vTv Therapeutics Inc - Class A | 17944.71 | +220375.18% |
| DSGN | Design Therapeutics Inc | 29402.82 | +361153.65% |
| TRML | Tourmaline Bio Inc | 30893.12 | +379464.05% |
| TIL | Instil Bio Inc | 54248.82 | +666420.57% |
| ETNB | 89bio Inc | 111568.68 | +1370673.00% |
| EDSA | Edesa Biotech Inc | 130462.29 | +1602806.75% |
| SVRA | Savara Inc | 145272.62 | +1784771.80% |
| AKTX | Akari Therapeutics Plc | 478368.50 | +5877307.92% |
| NKTX | Nkarta Inc | 1.00M | +12286260.67% |